A Case Report of COVID-19 in a Living Kidney Transplant Recipient: A Challenging Case with Complete Rehabilitation

Abstract

Adjustment of immunosuppressive and COVID-19 treatment in terms of drug interactions is still challenging. Herein, we report a 45-year-old woman with end-stage renal disease due to autosomal dominant polycystic diseases (ADPKD) with COVID-19 and pulmonary involvement following kidney transplantation. The patient was properly treated by discontinuation of immunosuppressive drugs, bronchoscopy, and high volume of blood transfusions. The fact that we quickly used early intubation and a new treatment regimen that suppressed immune systems may help physicians develop optimal treatment strategies for similar severe cases. However, this treatment method requires more detailed evaluations due to the contradictory results in reviewing other studies.

Pulmonary Tuberculosis With Tuberculous Right Wrist Tenosynovitis, Hepatitis C, and Mild COVID-19 in a Kidney Transplant Indian Male: World’s First Case

“…COVID-19 is also reported in kidney transplant cases and immunosuppressive therapy including antilymphocyte therapy, a calcineurin inhibitor (e.g., Tac), high-dose corticosteroids, and mycophenolate mofetil may influence health status making patients more susceptible to COVID-19 [ 9 ]. Further, the adjustment of immunosuppressants and drugs for COVID-19 treatment to overcome drug interactions is a challenging task [ 9 ].…”